Self-emulsifying lipid formulation: an overview.

Area of Science:

• Pharmaceutical Sciences
• Drug Delivery Systems
• Biopharmaceutics

Background:

• Oral drug development requires candidates with adequate aqueous solubility and resistance to first-pass metabolism to ensure bioavailability.
• Biopharmaceutical Classification System (BCS) class II and IV drugs often exhibit low aqueous solubility, posing formulation challenges.
• Existing strategies like particle size reduction and solid dispersions address solubility but not high metabolism.

Purpose of the Study:

• To review the formulation aspects of self-emulsifying lipid formulations (SELF).
• To explore the potential of SELF in mitigating bioavailability issues for lipophilic and highly first-pass metabolized drugs.
• To highlight the importance of understanding SELF components, gastrointestinal behavior, and drug release mechanisms.

Main Methods:

• Literature review focusing on self-emulsifying lipid formulations (SELF).
• Analysis of formulation strategies for improving oral drug bioavailability.
• Discussion of challenges related to low aqueous solubility and high first-pass metabolism.

Main Results:

• SELF formulations offer a promising approach to bypass first-pass metabolism and improve oral bioavailability.
• Successful SELF formulation necessitates a deep understanding of excipients, gastrointestinal dynamics, and drug release kinetics.
• SELF can effectively deliver lipophilic drugs with high intestinal and hepatic metabolism.

Conclusions:

• Self-emulsifying lipid formulations (SELF) are a viable strategy for enhancing the oral bioavailability of challenging drug candidates.
• Further research into SELF formulation and behavior is crucial for optimizing drug delivery.
• SELF technology holds significant potential for overcoming bioavailability hurdles in pharmaceutical development.